• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索1,2,4-三唑衍生物作为14α-脱甲基酶(CYP51)抑制剂的中、长臂延伸物。

Exploring medium and long arm extensions of 1,2,4-triazole derivatives as 14α-demethylase (CYP51) inhibitors.

作者信息

Alsulaimany Marwa, Binjubair Faizah A, Tatar Esra, Kelly Diane E, Kelly Steven L, Warrilow Andrew G, Keniya Mikhail V, Monk Brian C, Parker Josie E, Simons Claire

机构信息

School of Pharmacy and Pharmaceutical Sciences, Cardiff University King Edward VII Avenue Cardiff CF10 3NB UK

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University 34668 Istanbul Turkey.

出版信息

RSC Med Chem. 2025 Mar 12;16(5):2270-2280. doi: 10.1039/d4md00863d. eCollection 2025 May 22.

DOI:10.1039/d4md00863d
PMID:40135142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11931565/
Abstract

Fungal infections have been described as a silent crisis affecting more than one billion people each year. At least 150 million of these cases involve severe and life threatening invasive fungal infections, accounting for approximately 1.7 million deaths annually. 1,2,4-Trizoles such as fluconazole and posaconazole are widely used antifungal agents, but azole resistance is an increasing problem requiring further study. 1,2,4-Triazole derivatives with medium and long arm extensions designed to bind within the CYP51 (CaCYP51) access channel were synthesised to study their inhibition of CaCYP51 (IC, MIC) and binding affinity ( ). A long arm extension using the amide linker was found to be most effective (13), giving an antifungal profile wild-type and resistant model fungal strains comparable with posaconazole.

摘要

真菌感染已被描述为一场无声的危机,每年影响着超过10亿人。其中至少1.5亿例涉及严重且危及生命的侵袭性真菌感染,每年导致约170万人死亡。氟康唑和泊沙康唑等1,2,4-三唑类药物是广泛使用的抗真菌剂,但唑类耐药性问题日益严重,需要进一步研究。合成了具有中长臂延伸结构、旨在结合CYP51(白色念珠菌CYP51)通道内的1,2,4-三唑衍生物,以研究它们对白色念珠菌CYP51的抑制作用(IC50、MIC)和结合亲和力( )。发现使用酰胺连接体的长臂延伸最为有效(13),其对野生型和耐药模型真菌菌株的抗真菌谱与泊沙康唑相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/66712f8be918/d4md00863d-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/0cd3765f48d5/d4md00863d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/a5db0a91d4c0/d4md00863d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/b193359d7817/d4md00863d-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/2a2e0d95c7e6/d4md00863d-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/657bdb5046b5/d4md00863d-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/6f3d3251b24a/d4md00863d-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/66712f8be918/d4md00863d-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/0cd3765f48d5/d4md00863d-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/a5db0a91d4c0/d4md00863d-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/b193359d7817/d4md00863d-s1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/2a2e0d95c7e6/d4md00863d-s2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/657bdb5046b5/d4md00863d-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/6f3d3251b24a/d4md00863d-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8d1/12097200/66712f8be918/d4md00863d-f5.jpg

相似文献

1
Exploring medium and long arm extensions of 1,2,4-triazole derivatives as 14α-demethylase (CYP51) inhibitors.探索1,2,4-三唑衍生物作为14α-脱甲基酶(CYP51)抑制剂的中、长臂延伸物。
RSC Med Chem. 2025 Mar 12;16(5):2270-2280. doi: 10.1039/d4md00863d. eCollection 2025 May 22.
2
Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans.靶向甾醇 14α-脱甲基酶(CYP51)的小分子抑制剂:合成、分子模拟及对白念珠菌的活性评价。
ChemMedChem. 2020 Jul 20;15(14):1294-1309. doi: 10.1002/cmdc.202000250. Epub 2020 Jun 22.
3
The Evolution of Azole Resistance in Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions.甾醇 14α-脱甲基酶(CYP51)通过氨基酸替代的逐步积累导致唑类耐药性的演变。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02586-18. Print 2019 May.
4
Exploring Long Arm Amide-Linked Side Chains in the Design of Antifungal Azole Inhibitors of Sterol 14α-Demethylase (CYP51).探索在甾醇14α-脱甲基酶(CYP51)抗真菌唑类抑制剂设计中的长臂酰胺连接侧链。
J Med Chem. 2025 Jun 12;68(11):10781-10799. doi: 10.1021/acs.jmedchem.4c02922. Epub 2025 May 22.
5
Azole affinity of sterol 14α-demethylase (CYP51) enzymes from Candida albicans and Homo sapiens.白念珠菌和人类固醇 14α-去甲基酶(CYP51)的唑类亲和力。
Antimicrob Agents Chemother. 2013 Mar;57(3):1352-60. doi: 10.1128/AAC.02067-12. Epub 2012 Dec 28.
6
Structural analyses of sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis.与唑类药物复合的甾醇14α-脱甲基酶的结构分析揭示了唑类介导的真菌甾醇生物合成抑制的分子基础。
J Biol Chem. 2017 Apr 21;292(16):6728-6743. doi: 10.1074/jbc.M117.778308. Epub 2017 Mar 3.
7
Azole binding properties of Candida albicans sterol 14-alpha demethylase (CaCYP51).白色念珠菌甾醇 14α-去甲基酶(CaCYP51)的唑类结合特性。
Antimicrob Agents Chemother. 2010 Oct;54(10):4235-45. doi: 10.1128/AAC.00587-10. Epub 2010 Jul 12.
8
S279 point mutations in Candida albicans Sterol 14-α demethylase (CYP51) reduce in vitro inhibition by fluconazole.白色念珠菌甾醇 14-α 脱甲基酶(CYP51)中的 S279 点突变降低了氟康唑的体外抑制作用。
Antimicrob Agents Chemother. 2012 Apr;56(4):2099-107. doi: 10.1128/AAC.05389-11. Epub 2012 Jan 17.
9
The amino acid substitution N136Y in Candida albicans sterol 14alpha-demethylase is involved in fluconazole resistance.白色念珠菌甾醇14α-脱甲基酶中的氨基酸取代N136Y与氟康唑耐药性有关。
Med Mycol. 2016 Oct 1;54(7):764-775. doi: 10.1093/mmy/myw023. Epub 2016 May 3.
10
Impact of Homologous Resistance Mutations from Pathogenic Yeast on Saccharomyces cerevisiae Lanosterol 14α-Demethylase.致病酵母同源抗性突变对酿酒酵母麦角甾醇 14α-脱甲基酶的影响。
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.02242-17. Print 2018 Mar.

本文引用的文献

1
Advancements in Combating Fungal Infections: A Comprehensive Review on the Development of Azole Hybrid Antifungals.抗真菌药物的研究进展:唑类杂合抗真菌药物的开发综述
Curr Top Med Chem. 2024;24(26):2288-2313. doi: 10.2174/0115680266319532240822050311.
2
Oteseconazole: First Approval.奥替康唑:首次获批。
Drugs. 2022 Jun;82(9):1017-1023. doi: 10.1007/s40265-022-01734-y.
3
Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles.氟康唑 - COX 抑制剂杂合体:一类具有双重作用的抗真菌唑类药物。
J Med Chem. 2022 Feb 10;65(3):2361-2373. doi: 10.1021/acs.jmedchem.1c01807. Epub 2022 Jan 27.
4
Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic.在 COVID-19 大流行期间,一家三级保健医院的念珠菌血症发病率上升。
Mycoses. 2021 Feb;64(2):152-156. doi: 10.1111/myc.13225. Epub 2020 Dec 10.
5
Pan-Echinocandin-Resistant Bloodstream Infection Complicating COVID-19: A Fatal Case Report.泛棘白菌素耐药血流感染并发新型冠状病毒肺炎:一例死亡病例报告
J Fungi (Basel). 2020 Sep 6;6(3):163. doi: 10.3390/jof6030163.
6
COVID-19 Associated Invasive Pulmonary Aspergillosis: Diagnostic and Therapeutic Challenges.新型冠状病毒肺炎相关侵袭性肺曲霉病:诊断与治疗挑战
J Fungi (Basel). 2020 Jul 22;6(3):115. doi: 10.3390/jof6030115.
7
Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans.靶向甾醇 14α-脱甲基酶(CYP51)的小分子抑制剂:合成、分子模拟及对白念珠菌的活性评价。
ChemMedChem. 2020 Jul 20;15(14):1294-1309. doi: 10.1002/cmdc.202000250. Epub 2020 Jun 22.
8
Aspiring Antifungals: Review of Current Antifungal Pipeline Developments.有潜力的抗真菌药物:当前抗真菌药物研发进展综述
J Fungi (Basel). 2020 Feb 25;6(1):28. doi: 10.3390/jof6010028.
9
The Evolution of Azole Resistance in Sterol 14α-Demethylase (CYP51) through Incremental Amino Acid Substitutions.甾醇 14α-脱甲基酶(CYP51)通过氨基酸替代的逐步积累导致唑类耐药性的演变。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02586-18. Print 2019 May.
10
Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.唑类耐药降低了四唑类抗真菌药物 VT-1161 的敏感性。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.02114-18. Print 2019 Jan.